SDGR Stock Recent News

A few recent news stories highlight the tremendous power of artificial intelligence to improve our world and boost business performance. A doctor says that the technology can be a key means of enabling healthcare to become more personalized and making diagnoses earlier.

Schrodinger, Inc. (SDGR) came out with a quarterly loss of $0.38 per share versus the Zacks Consensus Estimate of $1.36. This compares to loss of $0.48 per share a year ago.

Artificial intelligence (AI) is a powerful technology that will enable many businesses to both save money and accelerate growth. As a result, demand for powerful, efficient AI tools is likely to explode, and companies that can deliver them will be quite prosperous.

Today, we put Schrodinger, Inc. in the spotlight as we do a post fourth quarter results assessment on this intriguing developmental and software concern. The company's core software business continues to deliver steady sales growth, while Schrodinger continues to advance an intriguing early stage pipeline.

Drug discovery software developer Schrodinger Inc. (NASDAQ: SDGR) stock has been trying to recover after plummeting over 80% off its all-time high of $117 in January 2021. Schrodinger's artificial intelligence (AI) powered software technology platform utilizes physics-based modeling and sophisticated machine learning algorithms to help clients identify the suitable molecules to treat the desired ailments.

Schrödinger, Inc. (NASDAQ:SDGR ) Q4 2022 Earnings Conference Call February 28, 2023 4:30 PM ET Company Participants Jaren Madden - Senior Vice President, Investor Relations and Corporate Affairs Ramy Farid - Chief Executive Officer Geoff Porges - Chief Financial Officer Karen Akinsanya - President of R&D, Therapeutics Conference Call Participants Do Kim - Piper Sandler David Lebowitz - Citi Gary Nachman - BMO Capital Markets Wolf Chanoff - Bank of America Operator Thank you for standing by. Welcome to Schrödinger's Conference Call to review Fourth Quarter and Full Year 2022 Financial Results.

Schrodinger, Inc. (SDGR) delivered earnings and revenue surprises of 22% and 16.74%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?

NEW YORK--(BUSINESS WIRE)--Schrödinger (Nasdaq: SDGR), whose physics-based computational platform is transforming the way therapeutics and materials are discovered, will report its fourth quarter and full-year 2022 financial results on Tuesday, February 28, 2023, after the financial markets close. The company will host a conference call and webcast at 4:30 p.m. ET. The live webcast can be accessed under "News & Events" in the investors section of Schrödinger's website, https://ir.

Schrodinger has developed a software platform that uses advanced physics and machine learning methods to predict important aspects of molecules with high accuracy. Their platform can help find new drugs faster and cheaper and increase the chances of success in further testing.

SDGR's valuable segment is its software business which represents majority of the revenue. There is an increasing demand for AI/ML capabilities by biopharmaceutical companies.